Cargando…
An alternate binding site for PPARγ ligands
PPARγ is a target for insulin sensitizing drugs such as glitazones, which improve plasma glucose maintenance in patients with diabetes. Synthetic ligands have been designed to mimic endogenous ligand binding to a canonical ligand-binding pocket to hyperactivate PPARγ. Here we reveal that synthetic P...
Autores principales: | Hughes, Travis S., Giri, Pankaj Kumar, de Vera, Ian Mitchelle S., Marciano, David P., Kuruvilla, Dana S., Shin, Youseung, Blayo, Anne-Laure, Kamenecka, Theodore M., Burris, Thomas P., Griffin, Patrick R., Kojetin, Douglas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070320/ https://www.ncbi.nlm.nih.gov/pubmed/24705063 http://dx.doi.org/10.1038/ncomms4571 |
Ejemplares similares
-
Defining a conformational ensemble that directs activation of PPARγ
por: Chrisman, Ian M., et al.
Publicado: (2018) -
Pharmacological Repression of PPARγ Promotes Osteogenesis
por: Marciano, David P., et al.
Publicado: (2015) -
A structural mechanism for directing corepressor-selective inverse agonism of PPARγ
por: Brust, Richard, et al.
Publicado: (2018) -
Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ
por: Heidari, Zahra, et al.
Publicado: (2019) -
Anti-Diabetic Actions of a Non-Agonist PPARγ Ligand Blocking Cdk5-Mediated Phosphorylation
por: Choi, Jang Hyun, et al.
Publicado: (2011)